abstract |
(57) [Summary] Disclosed are pharmaceutical compositions for treating pulmonary diseases (particularly cystic fibrosis), which are substituted azetidinones of general formula (I) which are found to be potent elastase inhibitors. , With an (F) -actin shortening protein such as gelsolin. |